Literature DB >> 10889921

Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors.

B Shemirani1, D L Crowe.   

Abstract

Angiogenesis is the formation of capillaries from pre-existing blood vessels. Angiogenesis occurs in many developmental, physiologic, and pathologic processes including tumor growth. Previous studies have shown that angiogenesis is required for growth and metastasis of solid tumors. Fibroblast growth factors (FGF-1, -2) and vascular endothelial growth factor (VEGF) are extremely potent angiogenesis inducers by stimulating the proliferation and migration of capillary endothelial cells. Expression of these factors is upregulated in many solid tumors and correlates with high vascularity, lymph node metastasis, and poor clinical prognosis. Few studies have examined whether established head and neck squamous cell carcinoma (SCC) lines produce biologically active angiogenic factors. By immunoprecipitation, we detected FGF and VEGF proteins in cellular lysates of SCC lines. We also detected FGF-1 and -2 proteins in serum-free-conditioned medium from these lines. Conditioned medium from SCC lines significantly increased proliferation of human umbilical vein endothelial cells (HUVEC). This increased proliferation was abrogated by pre-incubation of conditioned medium with neutralizing antibodies to FGFs and VEGF. Conditioned medium from SCC lines also significantly stimulated HUVEC invasion across a reconstituted basement membrane. We concluded that head and neck SCC lines secrete biologically active angiogenic factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889921     DOI: 10.1016/s1368-8375(99)00052-4

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  [Rare entity of a macroscopically visible tumor cone of squamous cell carcinoma in the greater veins of the head and neck].

Authors:  S Hoefert; T Bloch; W Wierich; H Eufinger
Journal:  Mund Kiefer Gesichtschir       Date:  2006-01

2.  Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells.

Authors:  Marianne E Marshall; Trista K Hinz; Scott A Kono; Katherine R Singleton; Brady Bichon; Kathryn E Ware; Lindsay Marek; Barbara A Frederick; David Raben; Lynn E Heasley
Journal:  Clin Cancer Res       Date:  2011-06-14       Impact factor: 12.531

3.  Novel tumor growth inhibition mechanism by cell cycle regulator cdk2ap1 involves antiangiogenesis modulation.

Authors:  Olga Zolochevska; Marxa L Figueiredo
Journal:  Microvasc Res       Date:  2010-06-10       Impact factor: 3.514

4.  The role of KDR in the interactions between human gastric carcinoma cell and vascular endothelial cell.

Authors:  Juan Ren; Lei Dong; Cang-Bao Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

5.  Expression of sphingosine kinase gene in the interactions between human gastric carcinoma cell and vascular endothelial cell.

Authors:  Juan Ren; Lei Dong; Cang-Bao Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells.

Authors:  Ryuji Yasumatsu; Torahiko Nakashima; Muneyuki Masuda; Aya Ito; Yuichiro Kuratomi; Takashi Nakagawa; Shizuo Komune
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-27       Impact factor: 4.553

7.  Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts.

Authors:  Larissa Sweeny; Terence M Zimmermann; Zhiyong Liu; Eben L Rosenthal
Journal:  Oral Oncol       Date:  2012-07-13       Impact factor: 5.337

8.  Angiogenesis in head and neck cancer: a review of the literature.

Authors:  Codecà Carla; Ferrari Daris; Bertuzzi Cecilia; Broggio Francesca; Crepaldi Francesca; Foa Paolo
Journal:  J Oncol       Date:  2011-11-10       Impact factor: 4.375

9.  Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.

Authors:  Nabil F Saba; Pooja Vijayvargiya; Jan B Vermorken; Juan P Rodrigo; Stefan M Willems; Nina Zidar; Remco de Bree; Antti Mäkitie; Greg T Wolf; Athanassios Argiris; Yong Teng; Alfio Ferlito
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

10.  Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?

Authors:  Aini Hyytiäinen; Wafa Wahbi; Otto Väyrynen; Kauko Saarilahti; Peeter Karihtala; Tuula Salo; Ahmed Al-Samadi
Journal:  Front Oncol       Date:  2021-06-14       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.